In addition it addresses the FDA’s communications Using the applicant, the retention of documents that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of an SE report back to a whole new applicant and electronic submission of your SE report an